Background: The association of human leukocyte antigen (HLA) genes and multiple sclerosis (MS) has been extensively investigated in Caucasians, but less so in Oriental races such as Chinese.
Objectives: To review studies on association of HLA class II alleles with MS in the Chinese population.
Methods: An extensive search for published studies up to June 2010 was performed in the electronic databases. The meta-analysis facilities in the NCSS statistical package were utilized to analyze the findings in these studies. The odds ratios (ORs) of HLA-DR allele distributions in MS were analyzed against controls.
Results: Eleven case-control studies were identified: nine genotyping and two serotyping studies. Six genotyping studies were suitable for HLA-DRB1 allele meta-analysis, which showed that HLA-DRB1*15 was associated with risk of MS in the combined group (308 cases and 407 controls; OR 1.39) while the HLA-DRB1*09 and HLA-DRB1*0901 alleles were protective. When the equivalent serotypes in these six studies were combined with the results from the two serotyping studies (431 cases and 652 controls) for a meta-analysis of HLA-DR serotypes, HLA-DR2 was a risk factor (OR 1.63) and HLA-DR9 was strongly protective in the combined group (OR 0.64).
Conclusions: Although limited data are available, our meta-analysis suggests that HLA-DR2/DRB1*15 are also associated with risk of MS in the Chinese population but less strongly so than in Western MS populations, whereas HLA-DR9 alleles appear to confer resistance in this population.
DymentDAEbersGCSadovnickAD. Genetics of multiple sclerosi?Lancet Neurol2004; 3: 104–110.
2.
RasmussenHBKellyMAClausenJ. Additive effect of the HLA-DR15 haplotype on susceptibility to multiple sclerosi?Mult Scler2001; 7: 91–93.
3.
WuJSJamesIQiuW. HLA-DRB1 allele heterogeneity influences multiple sclerosis severity as well as risk in Western Australi?J Neuroimmunol2010; 219: 109–113.
4.
WenBLiHLuD. Genetic evidence supports Demic diffusion of Han cultur?Nature2004; 431: 302–305.
5.
YuYLWooEHawkinsBRHoHCHuangCY. Multiple sclerosis amongst Chinese in Hong Kon?Brain1989; 112: 1445–1467.
6.
HouJBZhangZX. Prevalence of multiple sclerosis: a door-to-door survey in Lan Cang La Hu Zu Autonomous County, Yunnan Province of Chin?Neuroepidemiology1992; 11: 52–52.
7.
ChengQMiaoLZhangJ. A population-based survey of multiple sclerosis in Shanghai, Chin?Neurology2007; 68: 1495–1500.
8.
HawkinsBRYuYLWooEHuangCY. No apparent association between HLA and multiple sclerosis in southern Chines?J Neurol Neurosurg Psychiatry1988; 51: 443–445.
9.
SerjeantsonSWGaoXHawkinsBRHigginsDAYuYL. Novel HLA-DR2-related haplotypes in Hong Kong Chinese implicate the DQB1*0602 allele in susceptibility to multiple sclerosi?Eur J Immunogenet1992; 19: 11–19.
10.
DekkerJWEastealSJakobsenIB. HLA-DPB1 alleles correlate with risk for multiple sclerosis in Caucasoid and Cantonese patients lacking the high-risk DQB1*0602 allel?Tissue Antigens1993; 41: 31–36.
11.
KellyMAZhangYPennyMA. Genetic susceptibility to multiple sclerosis in a Shanghai Chinese population. The role of the HLA class II gene?Hum Immunol1995; 42: 203–208.
12.
BarcellosLFThomsonGCarringtonM. Chromosome 19 single-locus and multilocus haplotype associations with multiple sclerosis. Evidence of a new susceptibility locus in Caucasian and Chinese patient?JAMA1997; 278: 1256–1261.
13.
LiSHuX. Correlation between HLA-DRB1 alleles and genetic susceptibility in multiple sclerosi?Chin J Neurology1999; 32: 332–334.
14.
ZhangYZhuXCShengFX. Association study between HLA class II gene and genes related to antigen-presenting with multiple sclerosis in Shanghai Chines?Chinese J Microbiol Immunol1999; 19: 406–409.
15.
WangKWangGXLiuXZ. HLA-DRB1 allelic types and susceptibility to multiple sclerosi?Chinese J Neurol2003; 36: 21–24.
16.
MAJSunCLiLTa KahikoS. Comparison of brain evoked potentials and HLA gene polymorphisms in Asian and Western types of multiple sclerosi?Henan Med J2004; 13: 146–148.
17.
FangliBLiuGWangYZhangX. HLA DRB1 genotype and susceptibility to multiple sclerosis in Chinese Northern Han rac?Chinese J Neuroimmunol Neurol2008; 15: 400–403.
18.
LiangJChuLZX. Association between polymorphisms in HLA-II genes and multiple sclerosis in Guizhou Provinc?Chinese J Neurol2008; 41: 83–86.
19.
WuXMWangCZhangKN. Association of susceptibility to multiple sclerosis in Southern Han Chinese with HLA-DRB1, -DPB1 alleles and DRB1-DPB1 haplotypes: distinct from other population?Mult Scler2009; 15: 1422–1430.
20.
PeiJXuWSunS. HLA and Chinese multiple sclerosi?HLA in Asia-Oceania:proceedings of the third Asia-Oceania histocompatibility workshop and conference held in Sapporo, Japan1986; Sapporo, Japan: Hokkaido University Press, 726–729.
21.
PoserCMPatyDWScheinbergL. New diagnostic criteria for multiple sclerosis: guidelines for research protocol?Ann Neurol1983; 13: 227–231.
22.
McDonaldWICompstonAEdanG. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosi?Ann Neurol2001; 50: 121–127.
23.
WasayMKhatriIAKhealaniBSheeraniM. MS in Asian countrie?Int MS J2006; 13: 58–65.
24.
KiraJ. Multiple sclerosis in the Japanese populatio?Lancet Neurol2003; 2: 117–127.
25.
ChunjieXIAOLL. Cavalli-Sforza, E. Minch and Ruofu D. Principal component analysis of gene frequencies of Chinese population?Sci China C Life Sci2000; 43: 472–481.
26.
LeeTDZhaoTMMickeyR. The polymorphism of HLA antigens in the Chines?Tissue Antigens1988; 32: 188–208.
27.
Middleton D, Menchaca L, Rood H and Komerofsky R. New allele frequency database: http://www.allelefrequencies.net. Tissue Antigens 2003; 61: 403–407.
28.
RamagopalanSVEbersGC. Epistasis: multiple sclerosis and the major histocompatibility comple?Neurology2009; 72: 566–567.
29.
ChangKHLyuRKChenCM. Clinical characteristics of multiple sclerosis in Taiwan: a cross-sectional stud?Mult Scler2006; 12: 501–506.
30.
MaJJNishimuraMMineH. HLA-DRB1 and tumor necrosis factor gene polymorphisms in Japanese patients with multiple sclerosi?J Neuroimmunol1998; 92: 109–112.
31.
KiraJKanaiTNishimuraY. Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorder?Ann Neurol1996; 40: 569–574.
32.
RamagopalanSVMorrisAPDymentDA. The inheritance of resistance alleles in multiple sclerosi?PLoS Genet2007; 3: 1607–1613.
33.
Fernandez O, R-Antiguedad A, Pinto-Medel MJ, et al. HLA class II alleles in patients with multiple sclerosis in the Biscay province (Basque Country, Spain). J Neurol 2009.
34.
StankovichJButzkuevenHMarriottM. HLA-DRB1 associations with disease susceptibility and clinical course in Australians with multiple sclerosi?Tissue Antigens2009; 74: 17–21.
35.
BalleriniCGueriniFRRombolaG. HLA-multiple sclerosis association in continental Italy and correlation with disease prevalence in Europ?J Neuroimmunol2004; 150: 178–185.
36.
FukazawaTKikuchiSMiyagishiR. HLA-DPB1*0501 is not uniquely associated with opticospinal multiple sclerosis in Japanese patients. Important role of DPB1*030?Mult Scler2006; 12: 19–23.
37.
LincolnMRRamagopalanSVChaoMJ. Epistasis among HLA-DRB1, HLA-DQA1, and HLA-DQB1 loci determines multiple sclerosis susceptibilit?Proc Natl Acad Sci U S A2009; 106: 7542–7547.
38.
MatsuokaTMatsushitaTOsoegawaM. Heterogeneity and continuum of multiple sclerosis in Japanese according to magnetic resonance imaging finding?J Neurol Sci2008; 266: 115–125.
